- Home
- ANVS vs DOMH Comparison
ANVS vs DOMH Comparison
Compare ANVS & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ANVS | DOMH |
|---|---|---|
| Founded | 2008 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.1M | 73.3M |
| IPO Year | 2019 | 2010 |
Fundamental Metrics
Financial Performance| Metric | ANVS | DOMH |
|---|---|---|
| Price | $1.78 | $3.16 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $13.50 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 172.9K |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 23.45% |
| EPS Growth | ★ 39.39 | 34.03 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $123,104,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 578.41 |
| 52 Week Low | $1.54 | $2.69 |
| 52 Week High | $5.50 | $8.40 |
Technical Indicators
Market Signals| Indicator | ANVS | DOMH |
|---|---|---|
| Relative Strength Index (RSI) | 43.60 | 47.13 |
| Support Level | $1.79 | $2.84 |
| Resistance Level | $2.38 | $3.45 |
| Average True Range (ATR) | 0.14 | 0.25 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 19.17 | 17.89 |
Price Performance
Historical ComparisonAbout ANVS Annovis Bio Inc.
Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.
About DOMH Dominari Holdings Inc.
Dominari Holdings Inc is a holding company that, through its various subsidiaries, is engaged in wealth management, investment banking, sales and trading, asset management, and insurance. In addition to capital investment, Dominari provides management support to the executive teams of its subsidiaries, helping them to operate efficiently and reduce costs under a streamlined infrastructure. The Company operates in two reportable business segments: Dominari Financial and Legacy AIkido, with the majority of revenue from Dominari Financial.